NEW YORK, November 14, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
Today, Analysts' Corner announced new research reports highlighting Walgreen Company (NYSE: WAG),
AmerisourceBergen Corp. (NYSE: ABC), GNC Holdings Inc. (NYSE: GNC), Valeant Pharmaceuticals Intl Inc. (NYSE: VRX), and Omnicare, Inc. (NYSE: OCR). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
Walgreen Company Research Report
On November 8, 2013, Walgreen Company (Walgreens) announced that it has completed its acquisition of certain assets of Kerr Drug's retail drugstores and specialty pharmacy business. The Company stated that as previously in September 2013, this acquisition is an asset transaction and includes Kerr Drug's retail drugstores, specialty pharmacy business and a distribution center. According to the Company, in full-year FY 2012, Kerr Drug's retail drugstores and specialty pharmacy business recorded total sales of $381 million. The Full Research Report on Walgreen Company - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
AmerisourceBergen Corp. Research Report
On November 5, 2013, AmerisourceBergen Corp.'s (AmerisourceBergen) reported that its Board of Directors increased the quarterly dividend rate by 12%. The Company stated that the quarterly dividend now stands at c.$0.24 per share from the previous $0.21 per share. The Company informed that the dividend is payable on December 2, 2013 to stockholders of record at the close of business on November 18, 2013. The Full Research Report on AmerisourceBergen Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
GNC Holdings Inc Research Report
On November 11, 2013, GNC Holdings Inc (GNC) ended the trading day at $59.06, up by 2.04%. Shares of GNC rose 0.31% over the previous three trading days while the S&P 500 also rose 0.08% during that same period. The Full Research Report on GNC Holdings Inc - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
Valeant Pharmaceuticals Intl Inc. Research Report
On November 11, 2013, Valeant Pharmaceuticals Intl Inc.'s (Valeant) stocks slipped 0.27% to end the day at $105.16. Shares of Valeant slid by 1.21% over the three previous trading sessions, while the Dow Jones Industrial Average gained 0.23% during the same period. The Full Research Report on Valeant Pharmaceuticals Intl Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
Omnicare, Inc. Research Report
On November 8, 2013, Omnicare, Inc. (Omnicare) announced that it will present at the Credit Suisse 2013 Healthcare Conference on November 13, 2013 at 8:00 a.m. MT (10:00 a.m. ET) in Phoenix, Arizona. The Company informed that a live webcast of the event and its archived version can be accessed through its website. In other news dated November 1, 2013, Omnicare Specialty Care Group (SCG), a division of Omnicare, announced the opening of its new patient solutions center in Louisville, Kentucky. According to the Company, the expansion includes more than 120 workspaces to support the growth of its Brand Support platform, with services being provided through RxCrossroads. The Company stated that the new facility adds 18,000 square feet of call center space, bringing the total capacity to nearly 100,000 square feet across all six locations. Amit Jain, Senior Vice President of Sales and Marketing for Omnicare stated, "Omnicare SCG's expansion reflects the growing demand for access, affordability and adherence services for specialty pharmaceuticals. Brand support services continue to evolve in design and scope. The need to customize and integrate these services with other support functions, such as trial offerings or copay programs, is also expanding with our pharmaceutical partners. Our new, state-of-the-art patient solutions center enhances our ability to meet these evolving needs for our clients while better positioning Omnicare SCG for continued growth." The Full Research Report on Omnicare, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by Namrata Maheshwari, a CFA charterholder. However, we are only human and are prone to making mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
- For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Namrata Maheshwari, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts' Corner